Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Transpl Int. 2019 Feb 8;32(5):502–515. doi: 10.1111/tri.13395

Figure 2. Overall and Death-censored Allograft Survival after De novo DSA Detection was Similar Among Centers.

Figure 2

The incidence of death-censored allograft failure by one year post dnDSA was 8.0% (9/113); and by 3 year post-de novo DSA 32.2% (20/62) of the patients lost their graft. Overall allograft survival was 75.2% (85/113) (A) and death-censored allograft survival was 77.0% (87/113) (B) during a median follow-up of 2.2 (IQR 1.2–3.7) years following dnDSA detection.